AI Article Synopsis
- Marin-Amat syndrome is a condition characterized by involuntary eyelid closure during jaw movements, commonly occurring in patients with a history of facial palsy.
- A study of patients showed that most experienced ptosis (drooping eyelids), with significant changes in eyelid measurements noted after jaw movement, resulting from muscle contractions in the face.
- Treatment with Botox injections into the affected muscle effectively improved eyelid heights and alleviated ptosis symptoms in some patients, highlighting the condition's impact and potential management strategies.
Article Abstract
Purpose: Marin-Amat syndrome is an acquired facial synkinesis manifesting as involuntary eyelid closure on jaw movement. The authors investigate the clinical features, especially the quantitative changes in eyelid parameters of patients with Marin-Amat syndrome.
Methods: Patients with Marin-Amat syndrome between 2015 and 2017 in a medical center were collected. Clinical features and the change of eyelid parameters, including margin reflex distance 1 (MRD-1), margin reflex distance 2 (MRD-2), and palpebral fissure height, were evaluated.
Results: There were 5 men and 3 women with a mean age of 76 years. All had a history of facial palsy. The mean time to onset of Marin-Amat syndrome was 4.4 years after facial palsy. Seven patients (87.5%) developed subsequent ipsilateral facial spasm after facial palsy. Most patient complaints were ptosis (62.5%) and ptosis on eating (37.5%). The mean palpebral fissure height of involved eyes decreased from 5.88 to 2 mm on jaw opening (p = 0.011), which resulted from decrease in MRD-1 (from 2.06 to 0.06 mm, p = 0.012) and MRD-2 (from 3.81 to 1.94 mm; p = 0.012). Botulinum toxin A (Botox) injection into the periorbital orbicularis muscle in 6 patients significantly relieved the change of palpebral fissure height on jaw opening compared with that before injection (9.9% vs. 68.6 %, p = 0.027).
Conclusions: Most patients with Marin-Amat syndrome present with ptosis and might be overlooked or underestimated. The reduction in palpebral fissure height in our patients with Marin-Amat syndrome was due to involuntary orbicularis oculi muscle contraction, resulting in decrease of both the MRD-1 and MRD-2 on jaw opening.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/IOP.0000000000001538 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical Treatment of Synkinetic Eyelid Closure in Marin-amat Syndrome Complicated by Facial Palsy After COVID-19 Vaccination.
J Craniofac Surg
November 2024
Division of Plastic Surgery, Department of Surgery, Kaohsiung Municipal Ta-Tung Hospital.
Background: Marin-Amat syndrome is a rare, irreversible, and hard-to-treat neurological sequalae that has recently been associated with COVID-19 vaccination. Given the rarity of this condition and the absence of curative treatment to date, the authors herein review the literature to date and report the first ever successful surgical treatment of 2 patients who developed Marin-Amat syndrome after ChAdOx1 nCoV-19 vaccination.
Materials And Methods: In this case study, the authors treated Marin-Amat syndrome in a 45-year-old woman and a 75-year-old woman with facial palsy that developed 24 days and 4 months after receiving COVID-19 vaccination, respectively.
Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination.
Front Med (Lausanne)
November 2022
Department of Ophthalmology, Tri-Service General Hospital, Taipei, Taiwan.
While vaccination against COVID-19 is still ongoing, some rare adverse events temporally related to vaccinations have been reported, particularly with ChAdOx1 nCoV-19. Here, a 77-year-old male presented to our outpatient department with persistent ptosis of his left eye for 1 month. He initially received vaccination with ChAdOx1 nCoV-19 and developed symptoms of Bell's palsy 3 days later.
View Article and Find Full Text PDFMarin-Amat Syndrome: More Than Meets the Eye.
Neurology
January 2023
From the Neurology Department, Blacktown Hospital, Blacktown, NSW, Australia.
Background: Marin-Amat syndrome is a rare acquired oculofacial synkinesis first reported in 1918. It manifests as involuntary eyelid closure on jaw opening or on lateral movement of the jaw following a peripheral facial nerve palsy. The increased orbicularis tone due to aberrant connections between the cranial nerve (CN) V and CN VII results in an undesirable wink with major psychosocial impact.
View Article and Find Full Text PDFReply re: "Eyelid Parameter Changes in Patients With Marin-Amat Syndrome".
Ophthalmic Plast Reconstr Surg
April 2021
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!